Business directory profile

Turning Point Therapeutics


tptherapeutics.com


Access Company Details

Turning Point Therapeutics

Homepage http://www.tptherapeutics.com
LinkedIn Profile https://linkedin.com/company/tp-***apeut***
HQ Location United States , California, San Diego
10628 Science Center Drive Ste. 225 San Diego, CA 92121 United States
Last Update 2019-11-07
Manage your Business
TP Therapeutics, Inc. (TP) is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Our lead therapeutic project, TPX-0005, is in clinical development (TRIDENT-1). TP- Turning Point Medicines for Life!



Biotechnology and Molecular Biology Research

Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.

Career Opportunities at Turning Point Therapeutics



Employees of 'Turning Point Therapeutics'





Details of Turning Point Therapeutics

Founded in
2013
Services
Ocensore
Strcensoredcens oredce
Prcensore dcensore
Drce nsoredcens
Industry
Biotechnology and Molecular Biology Research
Company Type
Private Company
Enterprise Size
censo redcens
Headquartered
United States, California, San Diego
Website
http://www.tptherapeutics.com


Related Companies and Competitors




Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.